Medicine recalls
|
| |
| Singapore: Recall of one batch of Fluphenazin-neuraxpharm D 25 mg/ml solution for injection |
| |
Health Sciences Authority (HSA) announces that Alliance Pharm Pte Ltd is recalling one batch of Fluphenazin-neuraxpharm D 25 mg/ml solution for injection (fluphenazine decanoate) (batch number: 202052) to the retail level due to out of specification results.
Please refer to the following website in HSA for details:
http://www.hsa.gov.sg/announcements/product-recall/recall-of-one-batch-of-fluphenazin-neuraxpharm
In Hong Kong, Fluphenazin-neuraxpharm D Solution For Injection 25mg/ml (HK-64620) is a pharmaceutical product registered by Hind Wing Co Ltd (Hind Wing). The product is a prescription-only medicine.
On 1 Dec 2022, the Department of Health endorsed Hind Wing to recall one batch of Fluphenazin-neuraxpharm D Solution For Injection 25mg/ml (HK-64620) (batch number: 202052) due to potential quality issue. A recall statement was issued on the same date.
Ends/Tuesday, Dec 13, 2022
Issued at HKT 16:00
|
| |
|
